Can occur in anyone exposed to a neuroleptic/ drug blocker d2 (dopamine receptos).
Although it can occur at any time during treatment it is more common after starting the medication or increasing the dose. It is very rare with an incidence of 0.07-0.2%. Men are at greater risk than women. Other risk factors include history of nms, increased environmental temperature, dehydration